iBio, Inc. (NYSE AMEX: IBIO), the company commercializing the
iBioLaunch™ Platform for vaccines and biotherapeutics, announced that
its president, Mr. Robert Erwin, will present at SEVEN; Noble Financial
Capital Markets’ Seventh Annual Equity Conference, at the Hard Rock
Hotel in Hollywood, Florida, on Monday, May 16, ...
read more